Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Philippe Moriniere
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Procedures
Disorders
Chemicals & Drugs
Sign-in to see full Profile
Network (preview)
28
Fournier, Albert
9
Westeel, Pierre-François
8
El Esper, Najeh
7
Achard, Jean Michel
7
Oprisiu, Roxana
7
Sebert, Jean-Luc
5
Pruna, André
4
Brazier, Michel
4
Hottelart, Carine
3
Abighanem, O
3
Hardy, P
3
Ghazali, Abderrahmane
3
Makdassi, Raïfah
3
Mansour, Janette
3
Sechet, A
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Philippe Moriniere (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2007: Tillou Xavier; Moriniere Philippe; Hakami Farivar; Demailly Manuel; Fourmarier Marc; Westeel Pierre-François; Saint Fabien; Petit Jacques
[Proportion of surgical workload related to chronic renal failure in an urology and transplantation operating room]
Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie 2007;17(4):832-5.
-
2006: Bonne Jean-François; Mansour Jeanette; Moriniere Philippe; Shahapuni Irina; Fournier Albert
Current treatment options in secondary renal hyperparathyroidism.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006;21(10):2987-9; author reply 2989-90.
-
2005: Shahapuni Irina; Mansour Janet; Harbouche Laïd; Maouad Bechir; Benyahia Mohamed; Rahmouni Khelifa; Oprisiu Roxana; Bonne Jean-François; Monge Matthieu; El Esper Najeh; Presne Claire; Moriniere Philippe; Choukroun Gabriel; Fournier Albert
How do calcimimetics fit into the management of parathyroid hormone, calcium, and phosphate disturbances in dialysis patients?
Seminars in dialysis 2005;18(3):226-38.
-
2003: Mansour Janette; Benyahia Mohamed; Harbouche Leid; Presne Claire; Moriniere Philippe; Fournier Albert
Calcimetic AMG 073 at 50 and 100 mg per day.
Kidney international 2003;64(6):2324-5.
-
2003: Sadek Tarek; Mazouz Hakim; Bahloul Hedi; Oprisiu Roxana; El Esper Najeh; El Esper Isabelle; Boitte Francis; Brazier Michel; Moriniere Philippe; Fournier Albert
Sevelamer hydrochloride with or without alphacalcidol or higher dialysate calcium vs calcium carbonate in dialysis patients: an open-label, randomized study.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2003;18(3):582-8.
-
2001: Fournier A; Barsoum J; Fickl R; Oprisiu R; El Esper N; Moriniere P
Sevelamer, Ca x P product and vitamin D.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2001;16(2):429-30.
-
1999: Mazouz H; Kacso I; Ghazali A; El Esper N; Moriniere P; Makdassi R; Hardy P; Westeel P F; Achard J M; Pruna A; Fournier A
Risk factors of renal failure progression two years prior to dialysis.
Clinical nephrology 1999;51(6):355-66.
-
1998: Hardy-Yverneau P; Shenouda M; Moriniere P; Legallais C; Brazier M; Achard J; Fournier A
The dependency of calcium set point on basal plasma calcium in dialysis patients: a better explanation for the discrepancies regarding its link with PTH secretion than methodological differences.
Clinical nephrology 1998;50(4):236-46.
-
1998: Hottelart C; Achard J M; Moriniere P; Zoghbi F; Dieval J; Fournier A
Heparin-induced hyperkalemia in chronic hemodialysis patients: comparison of low molecular weight and unfractionated heparin.
Artificial organs 1998;22(7):614-7.
-
1998: Hardy P; Sechet A; Hottelart C; Oprisiu R; Abighanem O; Said S; Rasombololona M; Brazier M; Moriniere P; Achard J M; Pruna A; Fournier A
Inhibition of gastric secretion by omeprazole and efficiency of calcium carbonate on the control of hyperphosphatemia in patients on chronic hemodialysis.
Artificial organs 1998;22(7):569-73.
-
1998: Sechet A; Hardy P; Hottelart C; Rasombololona M; Abighanem O; Oualim Z; Brazier M; Achard J M; Pruna A; Moriniere P; Fournier A
Role of calcium carbonate administration timing in relation to food intake on its efficiency in controlling hyperphosphatemia in patients on maintenance dialysis.
Artificial organs 1998;22(7):564-8.
-
1998: Fournier A; Oprisiu R; Hottelart C; Yverneau P H; Ghazali A; Atik A; Hedri H; Said S; Sechet A; Rasolombololona M; Abighanem O; Sarraj A; El Esper N; Moriniere P; Boudailliez B; Westeel P F; Achard J M; Pruna A
Renal osteodystrophy in dialysis patients: diagnosis and treatment.
Artificial organs 1998;22(7):530-57.
-
1996: Fournier A; Oprisiu R; Moriniere P; El Esper N
Low doses of calcitriol or calcium carbonate for the prevention of hyperparathyroidism in predialysis patients?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1996;11(7):1493-5.
-
1995: Fournier A; Esper N E; Moriniere P; Oprisiu R; Marie A
Effect of alfacalcidol on renal bone disease in mild to moderate renal failure. Questions remain over alfacalcidol's efficacy in preventing secondary hyperparathyroidism.
BMJ (Clinical research ed.) 1995;311(6997):124; author reply 124-5.
-
1994: Fournier A; Moriniere P; Hamida F B; Ghazali A
CaCO3: an inefficient and unsafe phosphate binder?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1994;9(3):335-6.
-
1993: Moriniere P; el Esper N; Viron B; Judith D; Bourgeon B; Farquet C; Gheerbrant J; Chapuy M; Van Orshoven A; Pamphile R
Improvement of severe secondary hyperparathyroidism in dialysis patients by intravenous 1 alpha(OH) vitamin D3, oral CaCO3 and low dialysate calcium.
Kidney international. Supplement 1993;41():S121-4.
-
1991: Solal M E; Sebert J L; Boudailliez B; Marie A; Moriniere P; Gueris J; Bouillon R; Fournier A
Comparison of intact, midregion, and carboxy terminal assays of parathyroid hormone for the diagnosis of bone disease in hemodialyzed patients.
The Journal of clinical endocrinology and metabolism 1991;73(3):516-24.
-
1991: Achard J M; Westeel P F; Moriniere P; Lalau J D; de Cagny B; Fournier A
Pancreatitis related to severe acute hypertriglyceridemia during pregnancy: treatment with lipoprotein apheresis.
Intensive care medicine 1991;17(4):236-7.
-
1989: Moriniere P; Hocine C; Boudailliez B; Belbrik S; Renaud H; Westeel P F; Solal M C; Fournier A
Long-term efficacy and safety of oral calcium as compared to A1(OH)3 as phosphate binders.
Kidney international. Supplement 1989;27():S133-5.
-
1988: Demontis R; Westeel P F; Boudalliez B; Moriniere P; Leflon A; Abdulmassih Z; Atik H; Renaud H; Fournier A
1 alpha(OH) vitamin D3 increases plasma aluminum in hemodialyzed patients taking Al(OH)3.
Kidney international. Supplement 1988;24():S175-7.
-
1988: Fournier A; Moriniere P; Fohrer P; Leflon P; de Fremont J F; Marié A; Westeel P F; Renaud H; Tahiri Y; Idrissi A
Aluminum load and histological bone disease in hemofiltration and hemodialysis.
Kidney international. Supplement 1988;24():S168-70.
-
1988: Renaud H; Fournier A; Moriniere P; Westeel P F; el Esper N; Belbrik S; Marie A; Cohen-Solal H E; Sebert J L
Erosive osteoarthropathy associated with beta 2-microglobulin amyloidosis in a uraemic patient treated exclusively by long-term haemofiltration with biocompatible membranes.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1988;3(6):820-2.
-
1987: Fournier A; Moriniere P; Boudaillez B; Renaud H; Marie A; Westeel P F; Hocine C; Belbrik S
1,25 (OH)2 vitamin D3 deficiency and renal osteodystrophy: should its well-accepted pathogenetic role in secondary hyperparathyroidism lead to its systematic preventive therapeutic use?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1987;2(6):498-503.
-
1986: Moriniere P; Pourchez T; Renaud H
[Does the use of ticlopidine in chronic hemodialysed patients contra- indicate renal transplantation? A false problem?]
Presse médicale (Paris, France : 1983) 1986;15(33):1689.
-
1986: Demontis R; Leflon A; Fournier A; Tahiri Y; Herve M; Moriniere P; Abdull-Massih Z; Atik H; Belbrik S; Renaud H
1 alpha(OH) vitamin D3 increases plasma aluminum in hemodialized patients taking AI(OH)3.
Clinical nephrology 1986;26(3):146-9.
-
1986: Fournier A; Moriniere P; Sebert J L; Dkhissi H; Atik A; Leflon P; Renaud H; Gueris J; Gregoire I; Idrissi A
Calcium carbonate, an aluminum-free agent for control of hyperphosphatemia, hypocalcemia, and hyperparathyroidism in uremia.
Kidney international. Supplement 1986;18():S114-9.
-
1985: Fournier A; Sebert J L; Fohrer P; Moriniere P; Lambrey G; Herve M A; Leflon P; Gueris J; Garabedian M
Influence of biochemical and hormonal factors on the bone histomorphometric features of uraemic patients.
Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress 1985;21():415-20.
-
1985: Fournier A; Demontis R; Tahiri Y; Herve M; Moriniere P; Leflon A; Abdull-Massih Z; Atik H; Benelmouffok S
1 alpha OH vitamin D3 increases plasma aluminium in haemodialysed patients taking Al (OH)3.
Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress 1985;21():390-4.
-
1985: Fournier A; Fohrer P; Leflon P; Moriniere P; Tolani M; Lambrey G; Demontis R; Sebert J L; Van Devyver F; Debroe M
The desferrioxamine test predicts bone aluminium burden induced by A1(OH)3 in uraemic patients but not mild histological osteomalacia.
Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress 1985;21():371-6.
-
1985: Renaud H; Moriniere P; Dieval J; Abdull-Massih Z; Dkhissi H; Toutlemonde F; Delobel J; Fournier A
Low molecular weight heparin in haemodialysis and haemofiltration--comparison with unfractioned heparin.
Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress 1985;21():276-80.
-
1984: Fournier A; Sebert J L; Moriniere P; Gregoire I; de Fremont J F; Tahiri Y; Dkhissi H
Renal osteodystrophy: pathophysiology and treatment.
Hormone research 1984;20(1):44-58.
-
1983: Moriniere P; Roussel A; Tahiri Y; de Fremont J F; Maurel G; Jaudon M C; Gueris J; Fournier A
Substitution of aluminium hydroxide by high doses of calcium carbonate in patients on chronic haemodialysis: disappearance of hyperaluminaemia and equal control of hyperparathyroidism.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association 1983;19():784-7.
-
1983: Moriniere P; Tyan P; Fournier A; De Fremont J F; Deramond H; Ringot P; Gueris J
[Exploration by high-resolution real-time ultrasonography of the parathyroid glands in 60 chronic hemodialysis. Preliminary results and comparison with other indices of secondary hyperparathyroidism]
Néphrologie 1983;4(3):135-40.
-
1983: Tahiri Y; Moriniere P; Jaudon M C; Dkhissi H; Rosa A; Fournier A
[Hyperaluminemia in chronic hemodialysis patients. Evaluation of the respective roles of dialysate aluminum and oral aluminum hydroxide]
Néphrologie 1983;4(3):129-33.
-
1982: De Fremont J F; Coevoet B; Dkhissi H; Pruna A; Moriniere P; Galy C; Fournier A
Is blood urea nitrogen as good a guide for hemofiltration as for hemodialysis?
The New England journal of medicine 1982;307(16):1025-6.
-
1982: Sebert J L; Decourcelles P H; Moriniere P; de Fremont J F; Gueris J; Makdassi R; Khassouf J; Andrejak M; Fournier A
Effects of oral cimetidine on parathyroid hormone and calcitonin plasma levels in uremic patients.
Advances in experimental medicine and biology 1982;151():677-84.
-
1981: Makdassi R; Decourcelle P H; Moriniere P; Coevoet B; de Fremont J F; Kassouf J; Roussel A; Gheerbrand J D; Andrejak M; Fournier A
Blockers of beta and H2 receptors and secondary hyperparathyroidism in uraemia.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association 1981;18():642-7.
Sign-in to see more
